IBUS SEMINAR 2018 Emphasis on high risk lesions with consensus conference
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
IBUS SEMINAR 2018
Emphasis on high risk lesions
with consensus conference
MARCH 9-10, 2018
TECHNOPARK Zürich
PRELIMINARY PROGRAM
A seminar held under the patronage of the
Secretariat Office
meeting·com Congress Organisation
info@meeting-com.ch • T 021 312 92 61
Scientific board
Florian Dammann, Bern / Zürich, Switzerland
Rahel Kubik, Baden, Switzerland
Alexander Mundiger, Osnabrück, Germany
Christoph Rageth, Geneva, Switzerland
Christoph Tausch, Zürich, Switzerland
Zsuzsanna Varga, Zürich, Switzerland
Online registration www.meeting-com.ch / Conferences & Meetings / 2018Welcome
Dear Colleagues,
In the name of the organizing committee and the IBUS faculty members, we wish you a very warm
welcome to Zürich, and to this IBUS : Advanced Breast Ultrasound course.
This program will again demonstrate the top standards in comprehensive breast diagnosis and is
designed to circulate actual information concerning the whole scope of breast imaging. It is directed to
sonographers (radiologists, gynecologists and surgeons) who accept the importance of having a conclu-
sive diagnosis before any open surgery.
You will find yourself in the middle of a rejuvenated area of the city with many new facilities such as
cinemas, restaurants, hotels and also a number of shops. The Hardbrücke is the next town trains stop
approximately 800 meters from the meeting venue, and from there you can reach downtown by train
within a few minutes.
After having already met in Zürich for eight IBUS programs in the Technopark and the facilities of the
University Hospital of Zürich, we decided again for the Technopark, where teaching, learning and friend-
KliniK Hirslanden
ship could be best brought together under the one roof.
This part of the Technopark was built 25 years ago, and since 1993 hundreds of motivated, future-ori-
COMMiTTed TO THe
ented people have been working within the Technopark site in different fields which include industrial,
commercial and service enterprises and also in industry-oriented research teams.
The main goal will be to have again a consensus meeting and consensus statements regarding B3
HiGHesT sTandards lesions – this will (after 2016) be the second official international consensus conference on B3 lesions.
We wish you an enjoyable stay in Zürich, and hope that you will benefit from the expert faculty which
has come to share their knowledge with you.
We thank all the faculty members, sponsors, the European School of Oncology (ESO) and the Swiss
Klinik Hirslanden is one of Switzerland’s leading private hospitals and is part of the Hirslanden Private
Society of Senology who all support this IBUS meeting.
Hospital Group. Our patient-oriented approach and cutting-edge medicine informed by the latest
research shape our day-to-day activities. Hirslanden’s interdisciplinary network of experienced
medical specialists and the knowledge of our specialised centres of expertise ensure patients receive
integrated and comprehensive medical care. Patients can expect professional and personalised
assistance provided by our qualified nursing staff. Exceptional comfort, privacy and hotel-style service
round off the Hirslanden experience. For more information, please visit
Christoph Rageth (Chairman)
www.klinikhirslanden.ch
Local Organizing Committee
EXPERTISE YOU CAN TRUST.
3Organisation & Speakers General information
Congress office
Friday, March 9, 2018, 09.00-12.55 & 13.50-18.20
meeting·com Congress Organisation
1st day of IBUS 2018 Seminar
Rue des Pâquis 1 • 1033 Cheseaux-sur-Lausanne
T + 41 (0)21 312 92 61 • F +41 (0)21 312 92 63 • E info@meeting-com.ch
Saturday, March 10, 2018, 09.00-13.05 & 14.00-16.00
2nd day of IBUS 2018 Seminar
Online registration
www.meeting-com.ch / Conferences & Meetings
Venue
Technopark Zürich, Technoparkstrasse 1, 8005 Zürich Registration fees Until 18.02.18 From 19.02.18
info@technopark.ch – www.technopark.ch early bird & onsite
2 Days
Main speakers 9 & 10.3.18 CHF 600.00 ❒ CHF 850.00 ❒
Elizabeth A. Morris, MD, FACR, Memorial Sloan Kettering Cancer Center, New York (US) 9 & 10.3.18 – SSS members CHF 450.00 ❒ CHF 700.00 ❒
Elizabeth A. M. O’Flynn, MBBS, MRCS, FRCR, Consultant Radiologist, St. George’s Hospital, London (GB) 9 & 10.3.18 – residents* CHF 400.00 ❒ CHF 520.00 ❒
1 Day
Scientific board
9.3.18 CHF 400.00 ❒ CHF 500.00 ❒
Florian Dammann, Bern / Zürich
10.3.18 CHF 400.00 ❒ CHF 500.00 ❒
Rahel Kubik, Baden
Alexander Mundiger, Osnabrück (DE) Residents
Christoph Rageth, Geneva 9.3.18 CHF 270.00 ❒ CHF 350.00 ❒
Christoph Tausch, Zürich 10.3.18 CHF 270.00 ❒ CHF 350.00 ❒
Zsuzsanna Varga, Zürich * In order to benefit from the reduced fee for residents, you are required to send a document of your em-
ployer to the Seminar Secretariat by fax (+41 21 312 9263) or scanned (inscriptions@meeting-com.ch)
Invited speakers within 7 days from the date of application. The registration fee includes : access to the scientific sessions,
Pascal Baltzer, Vienna (AT) certificate of participation, coffee-breaks and lunches.
Andreas Boss, Zürich
Thomas Decker, Neubrandenburg (DE) Payment / Confirmation
Sophie Dellas, Basel Upon registration you will receive a written confirmation together with the banking details for the payment.
Michael Knauer, St. Gallen
Claudia Kurtz, Lucerne Cancellation
Caroline Malhaire, Paris (FR) In case of cancellation 30 days prior the event, the refund of the amount paid will be done net of
Martin Sonnenschein, Bern CHF 60.00 for administrative costs. Thereafter, no refund possible. Any registration made within the
“early bird” time must be paid during this period. It not the case, the invoice is automatically updated at
Seminar language the current price. Administrative costs will be charged to no shows. Legal jurisdiction is Lausanne.
English
Accreditation
In demand to the following societies :
Swiss Society for Gynaecology and Obstetrics
Swiss Society of Radiology
Swiss Society of Pathology
Swiss Society of Surgery
4 5Friday March 9, 2018 Friday March 9, 2018
IBUS 2018 – Emphasis on high risk lesions with consensus conference 11.15-11.30 Breast density : assessment and clinical implications
Elizabeth A. M. O’Flynn, London (GB)
11.30-11.45 The dense breast : how to image Elizabeth A. Morris, New York (US)
08.50-09.00 Welcome Scientific Board
11.45-11.50 Comments on dense breast imaging Andreas Boss, Zürich
09.00-09.15 New developments in ultrasound imaging Andreas Boss, Zürich
11.50-11.55 Comments on dense breast imaging Martin Sonnenschein, Bern
09.15-09.30 The new BI-RADS : what has changed & why
Elizabeth A. Morris, New York (US) 11.55-12.10 Intraoperative ultrasound and integration of ultrasound into surgical
practice Michael Knauer, St. Gallen
09.30-09.45 Imaging of recurrence (all modalities) Florian Dammann, Bern / Zürich
12.10-12.15 Comments on intraoperative ultrasound Christoph Tausch, Zürich
09.45-09.55 Detection of lymphnodes Martin Sonnenschein, Bern
12.15-12.20 Comments on CEM Elizabeth A. Morris, New York (US)
09.55-10.10 Needle biopsy of lymphnodes – when (after the Z0011 trial) and how
Michael Knauer, St. Gallen 12.20-12.35 Tomosynthesis : ethical not to perform ? Elizabeth A. Morris, New York (US)
10.10-10.25 How to manage the axilla initially N+ and clinically negative 12.35-12.45 Tomosynthesis new technical considerations Claudia Kurtz, Lucerne
after neoadjuvant chemotherapy - the radiologists’ view
12.45-12.55 Discussion
Sophie Dellas, Basel
10.25-10.40 How to manage the axilla initially N+ and clinically negative 12.55-13.50 Lunch break
after neoadjuvant chemotherapy - the surgeons’ view 13.50-14.05 New developments in MR imaging Pascal Baltzer, Vienna (AT)
Christoph Tausch, Zürich
14.05-14.20 Non mass like enhancement in MRI Rahel Kubik, Baden
10.40-10.50 Discussion
14.20-14.25 Comments on non mass like enhancement in MRI
10.50-11.15 Coffee break Pascal Baltzer, Vienna (AT)
14.25-14.40 Second look Ultrasound after suspicious MR Sophie Dellas, Basel
14.40-14.45 Comments on second look Ultrasound after suspicious MR
Pascal Baltzer, Vienna (AT)
14.45-14.55 Discussion
6 7Friday March 9, 2018 Saturday March 10, 2018
14.55-15.10 DCIS – imaging Claudia Kurtz, Lucerne IBUS 2018 – Emphasis on high risk lesions with consensus conference
15.10-15.25 Ultrasound imaging of DCIS - update of new insights 09.00-09.15 Does ABUS have a role in preoperative staging ?
Alexander Mundinger, Osnabrück (DE) Alexander Mundinger, Osnabrück (DE)
15.25-15.35 DCIS – pathology (pathological aspects of margins and size) 09.15-09.30 New clinical decision rules to avoid MRI-guided biopsies
Thomas Decker, Neubrandenburg (DE) Pascal Baltzer, Vienna (AT)
15.35-15.45 BI-RADS 3 - scourge of screening ? Elizabeth A. Morris, New York (US) 09.30-09.45 Indications of preoperative MRI : what are the best
Elizabeth A. M. O’Flynn, London (GB)
15.45-16.00 Review on pathological estimation of size and margins of DCIS
in surgical specimens Elizabeth A. Morris, New York (US) 09.45-10.00 Advanced functional MRI techniques Elizabeth A. M. O’Flynn, London (GB)
16.00-16.15 DCIS – surgery (margins, surgery vs. observation) 10.00-10.05 Discussion
Michael Knauer, St. Gallen
10.05-10.20 Deep learning : artificial intelligence for mammography assessment
16.15-16.30 High incidence of DCIS in screening - high risk of overdiagnosis ? Andreas Boss, Zürich
Thomas Decker, Neubrandenburg (DE)
10.20-10.30 Breast implant associated anaplastic large cell lymphoma
16.30-16.40 Discussion Caroline Malhaire, Paris (FR)
16.40-16.55 Evolution of benign breast lesions under neoadjuvant chemotherapy for 10.30-10.45 Can we avoid surgery after neoadjuvant chemotherapy ?
breast cancer and the difficulty to manage multiple breast additional Christoph Tausch, Zürich
lesions at MR staging of breast cancer before NAC
10.45-10.50 Discussion
Caroline Malhaire, Paris (FR)
10.50-11.10 MIBB database (VAB’s in Switzerland) update Christoph Rageth, Geneva
16.55-17.05 Can MRI predict reponsiveness of breast cancer to neoadjuvant therapy ?
Thomas Decker, Neubrandenburg (DE) 11.10-11.25 Risk lesions in minimally invasive biopsies: same pathological results –
different management Martin Sonnenschein, Bern
17.05-17.25 Coffee break
11.25-11.55 Coffee break
17.25-17.40 MRI as a problem solving tool a critical assessment of the evidence
Pascal Baltzer, Vienna (AT) 11.55-12.15 Introduction to the voting system and introductory questions
Christoph Rageth, Geneva
17.40-17.55 Multimodal ultrasound - where do we stand?
Alexander Mundinger, Osnabrück (DE) 12.15-12.30 Wrap up of the newest literature in lobular neoplasia
Zsuzsanna Varga, Zürich
17.55-18.10 Addition of ultrasound to mammographic screening
Florian Dammann, Bern / Zürich 12.30-12.40 Consensus finding
18.10-18.20 Elastography Claudia Kurtz, Lucerne 12.40-12.55 Wrap up of the newest literature in flat epithelial atypia
Zsuzsanna Varga, Zürich
12.55-13.05 Consensus finding
13.05-14.00 Lunch break
8 9Saturday March 10, 2018 Kind thanks to our sponsors
14.00-14.15 Wrap up of the newest literature in Phyllodes tumors
Zsuzsanna Varga, Zürich
14.15-14.25 Consensus finding
14.25-14.40 Wrap up of the newest literature in papillomas
Zsuzsanna Varga, Zürich
14.40-14.50 Consensus finding
14.50-15.05 Wrap up of the newest literature in radial scars
Thomas Decker, Neubrandenburg (DE)
15.05-15.15 Consensus finding
15.15-15.30 Wrap up of the newest literature in atypical ductal hyperplasia
Zsuzsanna Varga, Zürich
15.30-15.45 250 cases of ADH in CNB and VAB - experience of the Zurich breast
center Christoph Rageth, Geneva
15.45-15.50 Discussion
15.50-16.00 Consensus finding
16.00 Take home message & Farewell
Scientific Board
16.15 END OF IBUS SEMINAR 2018
& handout of certificates of attendance
10 11Registration form IBUS SEMINAR 2018
To be faxed or mailed back to
meeting.com Sàrl • Rue des Pâquis 1 • 1033 Cheseaux-sur-Lausanne
Fax +41 (0) 21 312 92 63 • Tel. +41 (0)21 312 92 61 • E-mail info@meeting-com.ch
Registration and payment online through
www.meeting-com.ch
Title _______________________________ (Prof., Dr, Mrs, Mr )
Family name _________________________ First name ________________________________
Institution ___________________________________________________________________
Street / Adresse _______________________________________________________________
Postal Code ______________ City ___________________ Country ________________________
Email ______________________________@_______________________________________
Registration fees Until 18.02.18 From 19.02.18
early bird & onsite
2 Days
9 & 10.3.18 CHF 600.00 ❒ CHF 850.00 ❒
9 & 10.3.18 – SSS members CHF 450.00 ❒ CHF 700.00 ❒
9 & 10.3.18 – residents* CHF 400.00 ❒ CHF 520.00 ❒
1 Day
9.3.18 CHF 400.00 ❒ CHF 500.00 ❒
10.3.18 CHF 400.00 ❒ CHF 500.00 ❒
Residents
9.3.18 CHF 270.00 ❒ CHF 350.00 ❒
10.3.18 CHF 270.00 ❒ CHF 350.00 ❒
* In order to benefit from the reduced fee for residents, you are required to send a document of your em-
ployer to the Seminar Secretariat by fax (+41 21 312 9263) or scanned (inscriptions@meeting-com.ch)
within 7 days from the date of application. The registration fee includes : access to the scientific sessions,
certificate of participation, coffee-breaks and lunches.
Seminar Language
English
Payment / Confirmation
Upon registration you will receive a written confirmation together with the banking details for the payment.
Cancellation
In case of cancellation 30 days prior the event, the refund of the amount paid will be done net
of CHF 60.00 for administrative costs. Thereafter, no refund possible. Any registration made within the
« early bird » time must be paid during this period. It not the case, the invoice is automatically updated
at the current price. Administrative costs will be charged to no shows. Legal jurisdiction is Lausanne.
12You can also read
